Tetraphase plots Q4 launch for first antibiotic after long-awaited OK for eravacycline
It took a few years more than expected, but Tetraphase finally has a product to sell.
Late Monday, the biotech announced that the FDA has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
